Could Gefitinib Replace Adjuvant Chemo in NSCLC? Could Gefitinib Replace Adjuvant Chemo in NSCLC?

In patients with EGFR mutations, adjuvant targeted therapy with gefitinib gave better results with less toxicity than adjuvant chemotherapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news